SCHEMBL20015501

SCHEMBL20015501

C(=C/C1CCNCC1)\c1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ATM Q13315 1/20 0.50
MAPK1 P28482 2/20 0.42
IKBKB O14920 1/20 0.42
RAF1 P04049 1/20 0.42
RPS6KB1 P23443 1/20 0.42
AKT1 P31749 1/20 0.42
AKT2 P31751 1/20 0.42
KDR P35968 1/20 0.42
MAPKAPK2 P49137 1/20 0.42
PRKAG1 P54619 1/20 0.42
MAP2K1 Q02750 1/20 0.42
PRDX1 Q06830 1/20 0.42
PRKAA1 Q13131 1/20 0.42
MAPK14 Q16539 1/20 0.42
NEK1 Q96PY6 1/20 0.42
PRKAB1 Q9Y478 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8487174 0.84 NPC1 (0.47) NPC1RAB9AMEN1KMT2AATM
SCHEMBL29137583 0.76 NPC1 (0.46) NPC1RAB9AMEN1KMT2AATM
SCHEMBL29137582 0.76 NPC1 (0.46) NPC1RAB9AMEN1KMT2AATM
SCHEMBL27140897 0.74 KDM1A (0.51) KHK
SCHEMBL818902 0.74 KDM1A (0.51) KHK
SCHEMBL20015683 0.74 KDM1A (0.51) KHK
SCHEMBL9544699 0.73 NPC1 (0.47) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9544703 0.73 NPC1 (0.47) NPC1RAB9AMEN1KMT2AATM
Hydrochloric Acid SCHEMBL7469122 0.73 KDM1A (0.50) KHK
Hydrochloric Acid SCHEMBL27154699 0.73 KDM1A (0.50) KHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018055096-A1 DISUBTITUTED AZETIDINES, PYRROLIDINES, PIPERIDINES AND AZEPANES AS INHIBITORS OF MONOAMINE OXIDASE B FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITY OF LJUBLJANA (SI) 2018-03-29 WO disclosed